Aberrant regulation of transforming growth factor-alpha during the establishment of growth arrest and quiescence of growth factor independent cells. 1998

G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
Department of Biochemistry and Molecular Biology, Medical College of Ohio, Toledo, Ohio 43699-0008, USA. howellg@uthscso.edu

Autocrine transforming growth factor alpha (TGFalpha) is an important positive growth effector in malignant cells and plays a significant role in generating the growth factor-independent phenotype associated with malignant progression. However, the molecular mechanisms by which TGFalpha confers a growth advantage in progression is poorly understood. The highly tumorigenic cell line HCT116 up-regulates TGFalpha mRNA expression during growth arrest, whereas the poorly tumorigenic growth factor-dependent FET cell line down-regulates TGFalpha mRNA expression as it becomes quiescent. We have identified a 25-bp sequence at -201 to -225 within the TGFalpha promoter which mediates the differential regulation of TGFalpha expression during quiescence establishment in these two cell lines. This same sequence confers TGFalpha promoter responsiveness to exogenous growth factor or autocrine TGFalpha. The abberant upregulation of TGFalpha mRNA in quiescent HCT116 cells may allow them to return to the dividing state under more stringent conditions (nutrient replenishment alone) then quiescent FET cells (requires nutrients and growth factors). Antisense TGFalpha approaches showed that the dysregulated TGFalpha expression in quiescent HCT116 cells is a function of the strong TGFalpha autocrine loop (not inhibited by blocking antibodies) in these cells.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D012045 Regulatory Sequences, Nucleic Acid Nucleic acid sequences involved in regulating the expression of genes. Nucleic Acid Regulatory Sequences,Regulatory Regions, Nucleic Acid (Genetics),Region, Regulatory,Regions, Regulatory,Regulator Regions, Nucleic Acid,Regulatory Region,Regulatory Regions
D002453 Cell Cycle The complex series of phenomena, occurring between the end of one CELL DIVISION and the end of the next, by which cellular material is duplicated and then divided between two daughter cells. The cell cycle includes INTERPHASE, which includes G0 PHASE; G1 PHASE; S PHASE; and G2 PHASE, and CELL DIVISION PHASE. Cell Division Cycle,Cell Cycles,Cell Division Cycles,Cycle, Cell,Cycle, Cell Division,Cycles, Cell,Cycles, Cell Division,Division Cycle, Cell,Division Cycles, Cell
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M

Related Publications

G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
June 1992, Cancer research,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
February 2000, Journal of pediatric surgery,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
October 2003, Endocrinology,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
June 1991, Cancer research,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
March 1995, Pharmacological reviews,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
February 2017, Stem cells translational medicine,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
April 1991, Molecular endocrinology (Baltimore, Md.),
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
February 1996, The Journal of biological chemistry,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
January 1988, Advances in experimental medicine and biology,
G M Howell, and L E Humphrey, and R A Awwad, and D Wang, and A Koterba, and B Periyasamy, and J Yang, and W Li, and J K Willson, and B L Ziober, and K Coleman, and J Carboni, and M Lynch, and M G Brattain
September 2004, Molecular and cellular endocrinology,
Copied contents to your clipboard!